Capsugel will be sold for $2.375 billion in cash.
Pfizer announced plans to sell Capsugel (Peapack, NJ), the world’s leading provider of pharmaceutical and dietary supplement capsules, to private equity firm Kohlberg Kravis Roberts & Co. Capsugel will be sold for $2.375 billion in cash.
Last year, Capsugel generated approximately $750 million in revenue and manufactured more than 180 billion hard capsules. The transaction is expected to be completed this year. Capsugel will maintain its corporate presence in the United States and its global headquarters in New Jersey.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.